Lausanne

DGAP-News: R-LOGITECH S.A.M. considers tap issue on its existing bond 2018/2023

Retrieved on: 
Tuesday, February 16, 2021
Companies, Lausanne, Logitech, Logistics, Business, Articles

Monaco, 16 February 2021 - R-LOGITECH S.A.M., an international provider of port infrastructure and logistics services with its main focus on the natural resources sector, considers to increase its existing EUR 160 million 8.5% corporate bond 2018/2023 (ISIN: DE000A19WVN8) to finance existing projects and opportunities that result from the current market environment.

Key Points: 
  • Monaco, 16 February 2021 - R-LOGITECH S.A.M., an international provider of port infrastructure and logistics services with its main focus on the natural resources sector, considers to increase its existing EUR 160 million 8.5% corporate bond 2018/2023 (ISIN: DE000A19WVN8) to finance existing projects and opportunities that result from the current market environment.
  • R-LOGITECH is one of the leading international ports infrastructure operators and logistics services providers in the natural resources sector.
  • The Group's primary business lines are port and terminal management, logistics and technology solutions.
  • R-LOGITECH is a subsidiary of Monaco Resources Group S.A.M.

AC Immune’s Alzheimer’s Vaccine Generates Potent Anti-pTau Antibody Response in a Phase 1b/2a Study

Retrieved on: 
Thursday, February 11, 2021
Medical specialties, Medicine, Clinical medicine, Immune system, Immunology, Glycoproteins, Biotechnology, Vaccination, Antibody, Monoclonal antibody, Antigen, Vaccine

ACI-35.030 vaccination generated a potent antigen-specific antibody response against pTau in 100% of older patients with early AD, achieving antibody levels several orders of magnitude higher than pre-vaccination levels.

Key Points: 
  • ACI-35.030 vaccination generated a potent antigen-specific antibody response against pTau in 100% of older patients with early AD, achieving antibody levels several orders of magnitude higher than pre-vaccination levels.
  • ACI-35.030 is a first-in-class vaccine candidate designed to generate a specific antibody response against pTau proteins in the brain.
  • Notably, anti-pTau vaccination generates antibody responses with pharmacokinetic characteristics and target epitopes that differ substantially from the Companys anti-Tau monoclonal antibody semorinemab, highlighting the comprehensive and complementary nature of AC Immunes anti-Tau pipeline.
  • It builds on the success of AC Immunes ACI-35 vaccine, which demonstrated an early target-specific antibody response against pTau after the first injection in the vast majority of participants in a Phase 1b study in mild-to-moderate AD.

AC Immune Initiates Clinical Study of First-in-class Diagnostic for Parkinson’s Disease

Retrieved on: 
Monday, February 8, 2021
Neurodegenerative disorders, Geriatrics, Parkinson's disease, Psychiatric diagnosis, RTT, Medical specialties, Medicine, Health

AC Immune expects to report the results of the study in Q3 2021.

Key Points: 
  • AC Immune expects to report the results of the study in Q3 2021.
  • The clinical study is supported by the Michael J.
  • Fox Foundation for Parkinsons Research (MJFF), building on The Foundations significant funding of AC Immunes program since 2015.
  • AC Immune SA is a Nasdaq-listed clinical-stage biopharmaceutical company, which aims to become a global leader in precision medicine for neurodegenerative diseases.

Logitech Launches New Brand Campaign ‘DEFY LOGIC’

Retrieved on: 
Tuesday, February 2, 2021
Technology, Football, Audio, Video, Entertainment, Events, Concerts, General Entertainment, Celebrity, Sports, Other Technology, Telecommunications, Hardware, Music, Consumer electronics, VoIP, Companies, Lausanne, Logitech, Economy of Switzerland, Jaybird

Logitech (NASDAQ: LOGI) today announced the launch of a brand campaign, DEFY LOGIC , featuring creators, artists and activists who are defying expectations and breaking barriers to inspire and change the world.

Key Points: 
  • Logitech (NASDAQ: LOGI) today announced the launch of a brand campaign, DEFY LOGIC , featuring creators, artists and activists who are defying expectations and breaking barriers to inspire and change the world.
  • View the full release here: https://www.businesswire.com/news/home/20210202005433/en/
    Logitech Launches New Brand Campaign DEFY LOGIC (Photo: Business Wire)
    DEFY LOGIC celebrates people pursuing their passions and breaking new ground, despite what current conventions, past precedent or traditional thinking might suggest is possible, said Heidi Arkinstall, chief marketing officer at Logitech.
  • Brands of Logitech include Logitech , Logitech G , ASTRO Gaming , Streamlabs , Ultimate Ears , Jaybird and Blue Microphones .
  • Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A and/or its affiliates in the U.S. and other countries.

AC Immune Reports Progress for Therapeutic Programs Targeting the NLRP3 Inflammasome Pathway

Retrieved on: 
Friday, January 29, 2021
Branches of biology, Programmed cell death, NLRP3, Inflammasome, Caspase, NLRP, CARD domain, Apoptosis, Thirumala-Devi Kanneganti, Dapansutrile

AC immune is currently evaluating potential lead compounds for further in vivo efficacy and CNS delivery.

Key Points: 
  • AC immune is currently evaluating potential lead compounds for further in vivo efficacy and CNS delivery.
  • A critical component of the NLRP3 pathway is ASC (apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain), which is released by immune cells following NLRP3 inflammasome activation.
  • Prof. Andrea Pfeifer, CEO of AC Immune SA, commented: Accelerating our complementary programs targeting the NLRP3 pathway intra- and extracellularly is a core element of our growth execution strategy in 2021 and beyond.
  • Advancing multiple high-value assets targeting the inflammasome pathway further demonstrates AC Immunes ambition to shape a comprehensive pipeline addressing key targets in neurodegeneration.

Logitech Files Quarterly Report on Form 10-Q

Retrieved on: 
Thursday, January 21, 2021
Hardware, Audio, Video, Consumer electronics, Technology, Software, Companies, Lausanne, Logitech, Economy of Switzerland, Audio electronics

Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that on January 21, 2021, it filed with the U.S. Securities and Exchange Commission (SEC) its Quarterly Report on Form 10-Q for the third quarter of Fiscal Year 2021.

Key Points: 
  • Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that on January 21, 2021, it filed with the U.S. Securities and Exchange Commission (SEC) its Quarterly Report on Form 10-Q for the third quarter of Fiscal Year 2021.
  • Logitech designs products that have an everyday place in people's lives, connecting them to the digital experiences they care about.
  • Brands of Logitech include Logitech , Logitech G , ASTRO Gaming , Streamlabs , Blue Microphones , Ultimate Ears and Jaybird .
  • Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A. and/or its affiliates in the U.S. and other countries.

Pexip and Logitech Partnership Brings AI-Powered, Immersive Video Collaboration from the Desktop to the Meeting Room

Retrieved on: 
Thursday, January 14, 2021
Lausanne, Logitech, Companies, Economy of Switzerland

"We are thrilled to partner with Logitech to bring the Pexip meeting room experience to market.

Key Points: 
  • "We are thrilled to partner with Logitech to bring the Pexip meeting room experience to market.
  • The Pexip Room experience is secure by design, so users don't have to enter a pin number or remember to lock the room.
  • With Pexip Room and its partnership with Logitech, Pexip can deliver an end-to-end meeting experience for browser, desktop, mobile, and meeting room users, enabling people to meet with anyone from home or the office.
  • "Pexip breaks down collaboration barriers so everyone can meet, and the Pexip Room experience is an extension of this philosophy.

Pexip and Logitech Partnership Brings AI-Powered, Immersive Video Collaboration from the Desktop to the Meeting Room

Retrieved on: 
Thursday, January 14, 2021
Lausanne, Logitech, Companies, Economy of Switzerland

"We are thrilled to partner with Logitech to bring the Pexip meeting room experience to market.

Key Points: 
  • "We are thrilled to partner with Logitech to bring the Pexip meeting room experience to market.
  • The Pexip Room experience is secure by design, so users don't have to enter a pin number or remember to lock the room.
  • With Pexip Room and its partnership with Logitech, Pexip can deliver an end-to-end meeting experience for browser, desktop, mobile, and meeting room users, enabling people to meet with anyone from home or the office.
  • "Pexip breaks down collaboration barriers so everyone can meet, and the Pexip Room experience is an extension of this philosophy.

  Logitech Is Raising the Bar for the Video Conferencing Industry

Retrieved on: 
Thursday, January 14, 2021
Consumer electronics, Technology, VoIP, Audio, Video, Telecommunications, Hardware, Telecommunications, Teleconferencing, Technology, Lausanne, Logitech, Science and technology, Videotelephony, Consumer electronics, Technology, VoIP, Audio, Video, Telecommunications, Hardware, Telecommunications, Teleconferencing, Technology, Lausanne, Logitech, Science and technology, Videotelephony

Today, Logitech (SIX: LOGN) (NASDAQ: LOGI) is raising the bar on the video conferencing industry with a next generation portfolio of appliance and PC-based solutions that work with todays leading video conferencing services such as Microsoft Teams and Zoom.

Key Points: 
  • Today, Logitech (SIX: LOGN) (NASDAQ: LOGI) is raising the bar on the video conferencing industry with a next generation portfolio of appliance and PC-based solutions that work with todays leading video conferencing services such as Microsoft Teams and Zoom.
  • The new Logitech Rally Bar , purpose-built for mid-sized rooms, and Logitech Rally Bar Mini for small rooms, transform meetings with cinema-quality video and crisp, clear audio in an all-in-one design.
  • View the full release here: https://www.businesswire.com/news/home/20210114005305/en/
    Logitech is raising the bar on video conferencing with all new video appliances.
  • (Photo: Business Wire)
    Tweet Now: Logitech is raising the bar for todays hybrid workplaces with a next generation portfolio of small, medium, and large meeting room solutions.

AB2 Bio to Participate in Orphan Disease Panel Discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event

Retrieved on: 
Tuesday, January 5, 2021
Medical specialties, Autoinflammatory syndromes, Clinical medicine, Periodic fever syndrome, Hemophagocytic lymphohistiocytosis, Medicine

The panel is entitled Rare Advantages and Unique Challenges Faced by Orphan Companies.

Key Points: 
  • The panel is entitled Rare Advantages and Unique Challenges Faced by Orphan Companies.
  • AB2 Bio is building a late-stage clinical pipeline with Tadekinig alfa, a novel IL-18 binding protein with established clinical proof-of-concept in three, life-threatening orphan autoinflammatory indications.
  • Tadekinig alfa is currently in late-stage development for the treatment of severe orphan autoinflammatory diseases, including primary and secondary HLH and Stills disease.
  • AB2 Bio is building a late-stage clinical pipeline with Tadekinig alfa, a novel IL-18 binding protein with established clinical proof-of-concept in three, life-threatening orphan autoinflammatory indications.